Weill Cornell Medicine Urology
Weill Cornell Medicine Urology
Jim C. Hu, M.D.

Jim C. Hu, M.D.

Find a Physician

FIND A PHYSICIAN

Quickly search our world-class physicians and faculty by keyword, location and insurance provider.

Search

Weill Cornell Urology: Dr. Jim C. Hu - Partial Nephrectomy

"Transperineal Prostate Biopsy Safe, Effective Under Local Anesthesia"

"Transperineal Prostate Biopsy Safe, Effective Under Local Anesthesia" featuring Dr. Jim C. Hu, Ronald Lynch Professor of Urologic Oncology at Weill Cornell Urology and Attending Urologist at NewYork-Presbyterian Hospital. 

Retzius-Sparing Radical Prostatectomy - Jim C. Hu, MD of Weill Cornell Urology

https://youtu.be/d57oum9s_7Q 

Retzius-Sparing Radical Prostatectomy

Jim C. Hu, MD
Ronald P. Lynch Professor of Urologic Oncology
Director of the LeFrak Center for Robotic Surgery
Quality and Patient Safety Chair

To learn more about Dr. Hu, please visit: https://urology.weillcornell.org/jim-c-hu

Dr. Massimo Loda of Weill Cornell Pathology and Dr. Jim C Hu of Weill Cornell Urology/ NewYork-Presbyterian Hospital awarded the Prostate Cancer Foundation Special Challenge Award.

This award funds cross-disciplinary teams of investigators in strategic areas to help support transformational prostate cancer research to accelerate progress towards the reduction of death and suffering due to recurrent or advanced prostate cancer.

 

For more info on the Prostate Cancer Foundation, visit: https://www.pcf.org/

Use of Novel Modalities to Manage Prostate Cancer Varies Across United States

For both prostate diagnosis and treatment, there has been evidence demonstrating significant geographic variation in practice patterns,” said urologic oncologist Jim C. Hu, MD, MPH Read More

Experts urge medical societies to reconsider prostate cancer screening guidelines

“The ideal scenario would be for professional societies to recognize the long-term downstream benefits of PSA screening in terms of reducing the risk for prostate cancer metastases and death in men with more than a 10-year life expectancy,” said Dr. Jim Hu of Weill Cornell Urology. To learn more about prostate cancer screening guidelines, please click here

What Are the Long-Term Benefits of PSA Screening for Prostate Cancer?

"We hope that a better understanding of the benefits of the PSA test will help more men receive the right treatment at the right time and reduce the burden of metastatic prostate cancer," senior author Jim Hu, MD, MPH, of Weill Cornell Medicine Urology. Learn More

Commentary: Benefits of PSA Test for Prostate Cancer Substantially Greater than Generally Appreciated

"The benefits of the prostate-specific antigen (PSA) test to screen men for prostate cancer may be greater than the harm, say investigators at Weill Cornell Medicine, NewYork-Presbyterian Hospital, University of Washington School of Medicine - WWAMI and the Fred Hutchinson Cancer Research Center.

Prostatectomy of Mixed Mortality Benefit in Men with Cancer

Dr. Jim Hu, a professor of urologic oncology at New York Presbyterian/Weill Cornell, in New York City, told Reuters Health by email, "The challenge of randomized trials for prostate cancer is the long period of time needed for meaningful differences to occur, and in turn, practice patterns change as we wait for these events." Read More.

Pages

Find a Physician FIND A PHYSICIAN

© 2016 Weill Cornell Medicine All rights reserved.